Epidermal growth factor receptor (EGFR) gene mutation stands as one of the most prevalent driver genetic alterations in non-small cell lung cancer (NSCLC). While targeted therapies against EGFR have substantially enhanced patient prognosis, acquired resistance remains a core challenge that limits therapeutic efficacy....
Zhuo-Ying Li, Rui Liu, Jian-Ping Wu et al.· Frontiers in Oncology· 0 citations
Introduction Perineural invasion (PNI) occurs in the majority of pancreatic ductal adenocarcinoma (PDAC) cases and is strongly associated with local recurrence, neuropathic pain, and poor survival, yet no reliable method exists for its preoperative identification. Here, we developed and externally validated a multi-seq...
Zhi-Qiang Ouyang, Zheng-Rui Song, Zhi-Lin Li et al.· Frontiers in Artificial Inte...· 0 citations
This case highlights that preserved tumor MMR immunostaining does not exclude Lynch syndrome when clinical suspicion is high and Concurrent MSI and MMR immunohistochemistry, interpreted together with tumor sequencing and germline testing, may improve diagnosis, treatment selection, and familial risk assessment.
Jing-Jing Cai, Zhuo-Ying Li, Ting-Ting Han et al.· Clinical Case Reports· 0 citations
Computational analyses suggest a potential relationship between KIFC1-associated malignant states and tumor microenvironmental signaling, supporting its value as a prognostic biomarker and potential therapeutic target.
Linghan Tian, Yuan-Biao Wang, Li Huang et al.· Molecular Biology Reports· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.